X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Pharmaceutics

期刊標題檢索 PHARMACEUTICS 最新評論: How long does the general review process take? (2024-08-06)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Pharmaceutics]您好,您是該頁面的第 120128 位訪客。

期刊簡介
期刊名稱Pharmaceutics Pharmaceutics
LetPub Score
7.5
50 ratings
Rate

Reputation
8.3

Influence
6.5

Speed
9.6

期刊簡稱PHARMACEUTICS
ISSN1999-4923
h-index32
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.900.8921.005
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q132 / 183

自引率 (2023-2024)12.20%自引率趨勢
掲載範囲
Pharmaceutics (ISSN 1999-4923) is an open access journal which provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. It publishes reviews, regular research papers, communications,  and short notes. Covered topics include pharmacokinetics, toxicokinetics, pharmacodynamics, pharmacogenetics and pharmacogenomics, and pharmaceutical formulation. Our aim is to encourage scientists to publish their experimental and theoretical details in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
官方網站https://www.mdpi.com/journal/pharmaceutics
在線稿件提交https://login.mdpi.com/login?_target_path=https%3A%2F%2Fsusy.mdpi.com%2Fuser%2Flogin%3FauthAll%3Dtrue
開放訪問Yes
出版商MDPI (Basel, Switzerland)
主題領域Pharmacology, Toxicology and Pharmaceutics
出版國/地區Switzerland
發行頻率
創刊年2009
每年文章數2749每年文章數趨勢
黃金OA百分比99.64%
OA Related Info
APC: Yes( CHF2900; )
APC waiver:Check Notes
Other charges: No
Keywords: pharmacokinetics
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ145/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1999-4923%5BISSN%5D
平均審稿時間 *來自出版商的數據: 16.41 Day(s)
來自作者的數據: 11 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Pharmaceutics】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Asian Journal of Pharmaceutical SciencesH-index: 27

    CiteScore: 18.30
    Bioengineering & Translational MedicineH-index: 0

    CiteScore: 8.40
    Journal of Pharmaceutical InvestigationH-index: 0

    CiteScore: 10.20
    Cancer NanotechnologyH-index: 0

    CiteScore: 5.20
    PharmaceuticalsH-index: 0

    CiteScore: 6.10
    Advanced TherapeuticsH-index: 0

    CiteScore: 7.10
    SCIENTIA PHARMACEUTICAH-index: 0

    CiteScore: 4.60
    BioImpactsH-index: 0

    CiteScore: 4.80
    Drug Metabolism LettersH-index: 0

    CiteScore: 2.80
    Recent Patents on Drug Delivery and FormulationH-index: 0

    CiteScore: 2.30
    學科內最受檢索的期刊 頁面查看次數
    Pharmaceuticals62875
    Asian Journal of Pharmaceutical Sciences56479
    Bioengineering & Translational Medicine33082
    Advanced Therapeutics26124
    Cancer Nanotechnology12769
    BioImpacts6997
    International Journal of Pharmaceutics: X3318
    Journal of Pharmaceutical Investigation3270
    Recent Patents on Drug Delivery and Formulation2827
    Drug Metabolism Letters2696
  •  

    Pharmaceutics Pharmaceutics
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Pharmaceutics] 的評論撰寫評論
作者: 罗汉沈然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-06 19:43:02 評論於
How long does the general review process take?
(0) 讚! | 罗汉沈然

作者: 天山含芙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-04 16:27:49 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: Faster review process
(0) 讚! | 天山含芙

作者: 差不多就好


領域: 生物学
審稿時間: 4.0 month(s)
結果: 拒稿


撰寫評論

2023-12-28 22:32:44 評論於
Demoted to a third-tier journal of the Chinese Academy of Sciences, what do you think?
(0) 讚! | 差不多就好

作者: 风陵孤双


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-30 23:06:11 評論於
Have you voted?
(0) 讚! | 风陵孤双

作者: Rod Theresa


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-01 12:08:32 評論於
Is the magazine very strict about the manuscript format?
(0) 讚! | Rod Theresa

作者: 一吃就胖小萌阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-18 13:48:02 評論於
It has been almost a month since the submission, and it is still under review. What should I do?
(0) 讚! | 一吃就胖小萌阳

作者: 昭巫晶燕


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-16 19:47:41 評論於
How to find the journal's official website?
(0) 讚! | 昭巫晶燕

作者: 一吃就胖小萌阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-03 09:22:37 評論於
Hello, how is your article coming along now?
(0) 讚! | 一吃就胖小萌阳

作者: gren


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2022-10-09 21:11:09 評論於
The reviewer is very responsible and has provided very constructive comments. Many of them are very pertinent and have indeed improved the quality of the manuscript. The editor is also very diligent and responsible. The efficiency is more than double that of the usual magazines.
(0) 讚! | gren

作者: 凌波凌熙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-05 15:30:42 評論於
Hello, may I ask if Nanoparticles combined therapy can cure this disease?
(0) 讚! | 凌波凌熙

作者: 凌波凌熙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-05 13:01:56 評論於
How long did it take for your paper to be reviewed?
(0) 讚! | 凌波凌熙

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:56:58 評論於
Different journals may have different requirements, so it is necessary to follow the specific requirements of the journal to complete the submission
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:55:39 評論於
Journal websites will have author guidance, with detailed formatting requirements listed on the page
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 23:45:19 評論於
Are the format requirements the same for each journal?
(0) 讚! | 八坂篷蔚

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 13:11:28 評論於
How to find the format requirements for a specific journal?
(0) 讚! | 八坂篷蔚

作者: 销魂天赐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-04 17:05:50 評論於
It has been pending review for a week, and there has been no change. Is it a bad sign? ?
(0) 讚! | 销魂天赐

作者: 德温贝儿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-25 13:05:36 評論於
Review speed: 2.0
Experience sharing: The boss in the group is the editor of the sub-section, but it doesn't seem to be very useful. The editor directly gives opinions to two reviewers, one with a mediocre attitude and one more positive. Overall, the first review comments are given very quickly, receiving first review comments in about a month. After revising, they were accepted. The editorial office is very transparent, and all reviewer comments can be seen eventually. Good impression. Also saw articles by Chinese authors, and the speed is also similar. Generally, it is indeed easier to publish articles in Europe's schools than in China. Hope that Chinese journals will continue to improve in the future
(0) 讚! | 德温贝儿

作者: 盖尔莫尔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-04 10:31:28 評論於
Review speed: 1.0 Experience sharing: Journals not yet dominated by the Chinese are very fast in review speed, with very fair comments from reviewers, transparent review processes, and are relatively formal open access journals with high cost performance in the CSCI Zone II
(0) 讚! | 盖尔莫尔

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Pharmaceutics] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*